REMIUM
Remium provides capital and funding solutions to small and medium businesses.
REMIUM
Industry:
Crowdfunding Information Technology
Founded:
2000-01-01
Address:
Stockholm, Stockholms Lan, Sweden
Country:
Sweden
Website Url:
http://www.remium.com
Total Employee:
11+
Status:
Closed
Contact:
46 84 54 32 00
Email Addresses:
[email protected]
Technology used in webpage:
SSL By Default LetsEncrypt Domain Not Resolving DMARC Umbraco
Similar Organizations
Decimal
Decimal offers IT management solutions for small and medium enterprises.
IeTee Solutions
IeTee Solutions is an IT company that provides various cloud solutions for small and medium businesses.
Official Site Inspections
http://www.remium.com
- Host name: aec037177372cc6cd.awsglobalaccelerator.com
- IP address: 15.197.225.128
- Location: United States
- Latitude: 37.751
- Longitude: -97.822
- Timezone: America/Chicago
More informations about "Remium"
Ermium Therapeutics - Crunchbase Company Profile
Ermium Therapeutics was founded in June 2019 by Jean-Philippe HERBEUVAL, Kurma Partners, Idinvest Partners, Domain Therapeutics and Erganeo. The …See details»
Remium - Crunchbase Company Profile & Funding
Remium provides capital and funding solutions to small and medium businesses.See details»
ERMIUM THERAPEUTICS - Domain Therapeutics Group
Ermium therapeutics In 2019, Domain Therapeutics, invested €3M ($3.2M) in Ermium Therapeutics. Founded in June 2019 by Dr Jean-Philippe Herbeuval, Kurma Partners, Idinvest …See details»
Ermium Therapeutics - Products, Competitors, Financials, …
Ermium Therapeutics is a biotechnology company focused on developing innovative therapies for auto-immune diseases. Use the CB Insights Platform to explore Ermium Therapeutics's full …See details»
Ermium Therapeutics Extends Its Initial €6,3 M Funding to €12,3 M …
Jun 30, 2022 Ermium Therapeutics Joël Crouzet, PhD, CEO [email protected] Ulysse Communications – Press Relations Tel: +33 (0) 6 87 88 47 26 Bruno Arabian …See details»
Ermium Therapeutics 2025 Company Profile: Valuation, …
Ermium Therapeutics General Information Description. Developer of a biotechnology platform designed for the treatment of autoimmune inflammatory diseases. The company's platform engages in the research and development …See details»
Ermium Therapeutics SAS - Drug pipelines, Patents, Clinical trials ...
Explore Ermium Therapeutics SAS with its drug pipeline, therapeutic area, technology platform, 1 clinical trial, 2 news, Disease Domain:Immune System Diseases, Technology Platform:Small …See details»
Ermium Therapeutics - VentureRadar
Ermium Therapeutics is a biotech company developing innovative therapies for auto-immune diseases, based on a breakthrough discovery showing that CXCR4 is a master regulator of …See details»
Ermium Therapeutics SAS - life-sciences-europe.com
Jun 28, 2019 Ermium Therapeutics was founded in June 2019 by Jean-Philippe Herbeuval, Kurma Partners, Idinvest Partners, Domain Therapeutics and Erganeo. The company is based …See details»
Ermium Therapeutics - Overview, News & Similar companies
Feb 2, 2022 Ermium Therapeutics was founded in June 2019 by Jean-Philippe Herbeuval, Kurma Partners, Domain Therapeutics and the SATT Erganeo. The company is b ased in …See details»
Ermium Therapeutics Company Information - Funding, Investors, …
Ermium Therapeutics, based in Paris, shows strong potential in developing treatments for autoimmune diseases. Operating on a B2B model, the company collaborates with biotech and …See details»
Remium - Crunchbase Company Profile & Funding
Remium is a financial services company that operates within the United Kingdom. It is registered in England and Wales and is authorized by the Financial Conduct Authority.See details»
Ermium Therapeutics Fights Autoimmune Disease with Rare …
Oct 18, 2019 Ermium raised a Series A round of €6.3M last month to fund the development of its drugs, and is still in the stage of deciding which autoimmune condition to target first. The …See details»
Ermium Therapeutics - Contacts, Employees, Board Members
Ermium Therapeutics is a biotech company developing innovative therapies for auto-immune diseases. New. Resources. Advanced Search. Start Free Trial . Talk With Sales. Pricing. Log …See details»
Press release Erganeo helps launch start-up Ermium Therapeutics, …
Ermium Therapeutics was founded in June 2019 by Jean- Philippe Herbeuval, Kurma Partners, Domain Therapeutics and Erganeo. Based in Paris, the company signed a world exclusive …See details»
Ermium Therapeutics extends its initial €6,3 M funding to €12,3 M …
Paris, France, June 30th 2022 - Ermium Therapeutics, a Paris-based biotech company developing innovative health products for auto-immune diseases, announced today the …See details»
Domain Therapeutics invests in Ermium Therapeutics to develop …
Descartes University). Ermium’s molecules are the first that are able to target a newly identified active area on the CXCR4 receptor to inhibit the overproduction of inflammatory cytokines, …See details»
Ermium Therapeutics extends its initial €6.3 M funding to €12.3 M …
Jun 30, 2022 Ermium Therapeutics, a Paris-based biotech company developing innovative health products for auto-immune diseases, announced today the extension of its initial funding …See details»
What GroupM is telling staff about restructuring, rebranding and ...
11 hours ago He concluded the message by expressing that the organization is “building a stronger, more competitive company” poised to set “the standard as the most modern, …See details»
Communiqué de presse Erganeo participe à la création de la start …
Ermium Therapeutics a été fondée en juin 2019 par Jean-Philippe HERBEUVAL, Kurma Partners, Domain Therapeutics et Erganeo. La société est basée à Paris et a signé un accord de licence …See details»